Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 01:46PM ET
88.19
Dollar change
-0.93
Percentage change
-1.04
%
IndexS&P 500 P/E29.67 EPS (ttm)2.97 Insider Own0.08% Shs Outstand1.31B Perf Week-1.41%
Market Cap113.10B Forward P/E15.07 EPS next Y5.85 Insider Trans-1.91% Shs Float1.28B Perf Month-3.12%
Income3.93B PEG5.39 EPS next Q1.25 Inst Own85.15% Short Float0.99% Perf Quarter13.63%
Sales32.58B P/S3.47 EPS this Y4.86% Inst Trans1.50% Short Ratio1.96 Perf Half Y5.09%
Book/sh37.39 P/B2.36 EPS next Y7.35% ROA4.35% Short Interest12.70M Perf Year15.22%
Cash/sh6.12 P/C14.42 EPS next 5Y5.51% ROE7.92% 52W Range68.84 - 91.49 Perf YTD7.05%
Dividend Est.2.73 (3.10%) P/FCF21.98 EPS past 5Y-4.12% ROI5.29% 52W High-3.61% Beta0.85
Dividend TTM2.78 (3.15%) Quick Ratio1.61 Sales past 5Y1.24% Gross Margin60.13% 52W Low28.11% ATR (14)1.29
Dividend Ex-DateSep 27, 2024 Current Ratio2.13 EPS Y/Y TTM9.45% Oper. Margin17.95% RSI (14)47.10 Volatility1.10% 1.41%
Employees95000 Debt/Eq0.58 Sales Y/Y TTM3.23% Profit Margin12.05% Recom2.38 Target Price93.96
Option/ShortYes / Yes LT Debt/Eq0.55 EPS Q/Q35.53% Payout99.87% Rel Volume0.32 Prev Close89.12
Sales Surprise1.33% EPS Surprise2.59% Sales Q/Q2.77% EarningsAug 20 BMO Avg Volume6.46M Price88.19
SMA20-1.68% SMA502.28% SMA2005.26% Trades Volume1,376,451 Change-1.04%
Date Action Analyst Rating Change Price Target Change
Aug-21-24Reiterated Oppenheimer Perform $92 → $94
Aug-15-24Upgrade UBS Sell → Neutral $76 → $90
Aug-14-24Downgrade Stifel Buy → Hold $100 → $85
May-30-24Initiated Goldman Sell $83
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
May-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $104
Apr-24-23Upgrade Wells Fargo Equal Weight → Overweight $77 → $100
Mar-29-23Downgrade UBS Buy → Sell $127 → $79
Jan-09-23Downgrade RBC Capital Mkts Outperform → Sector Perform $102 → $89
Oct-02-24 04:11AM
Oct-01-24 10:00AM
Sep-30-24 04:52AM
Sep-27-24 07:00PM
09:40AM
05:50PM Loading…
Sep-26-24 05:50PM
11:23AM
04:12AM
Sep-25-24 08:34AM
08:23AM
08:00AM
07:53AM
Sep-20-24 11:54AM
Sep-19-24 11:30AM
08:02AM
07:13AM Loading…
07:13AM
Sep-18-24 06:32AM
04:52AM
Sep-14-24 05:36PM
10:05AM
Sep-12-24 10:15AM
07:00AM
Sep-10-24 02:02PM
Sep-08-24 10:01AM
Sep-05-24 06:00AM
Sep-04-24 06:19AM
Sep-03-24 04:32AM
01:21AM
Sep-02-24 06:53AM
Sep-01-24 08:45AM
06:00AM Loading…
Aug-30-24 06:00AM
Aug-28-24 06:58PM
Aug-27-24 07:02PM
03:58PM
Aug-26-24 09:00AM
Aug-24-24 02:03PM
Aug-21-24 06:31AM
04:04AM
Aug-20-24 04:04PM
03:49PM
03:45PM
02:48PM
02:30PM
01:30PM
12:11PM
11:45AM
11:37AM
11:29AM
11:26AM
09:30AM
07:55AM
07:12AM
07:02AM
07:02AM
06:53AM
06:45AM
Aug-19-24 04:49PM
11:18AM
10:12AM
09:30AM
09:00AM
07:53AM
05:52AM
Aug-18-24 08:30AM
Aug-17-24 10:17PM
09:05AM
Aug-16-24 07:00AM
Aug-15-24 02:06PM
12:32PM
10:20AM
09:15AM
03:00AM
Aug-14-24 04:23PM
11:42AM
10:58AM
09:50AM
Aug-13-24 05:45PM
01:45AM
Aug-12-24 08:29PM
06:00PM
04:20PM
03:01PM
10:53AM
Aug-08-24 07:13AM
04:52AM
Aug-07-24 04:57PM
08:07AM
08:00AM
02:45AM
Aug-06-24 05:45PM
04:16PM
07:07AM
Aug-02-24 08:00AM
Jul-31-24 05:45PM
12:30PM
Jul-30-24 05:15PM
Jul-29-24 05:50PM
04:30PM
Jul-26-24 10:00AM
Jul-25-24 12:30PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PARKHILL KAREN LFormer OfficerAug 26 '24Proposed Sale90.002,668240,120Aug 26 02:11 PM
Wall Brett A.EVP & Pres NeuroscienceAug 02 '24Option Exercise0.005,311049,169Aug 06 06:16 PM
Walter Matthew R.SVP, Chief HR OfficerAug 02 '24Option Exercise0.00684025,889Aug 06 06:15 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 02 '24Option Exercise0.003,490064,757Aug 06 06:14 PM
Salmon SeanEVP & President CardiovascularAug 02 '24Option Exercise0.005,462068,546Aug 06 06:14 PM
PARKHILL KAREN LEVP & Chief Financial OfficerAug 02 '24Option Exercise0.007,132053,459Aug 06 06:13 PM
Martha GeoffreyChairman and CEOAug 02 '24Option Exercise0.0018,9660203,086Aug 06 06:13 PM
Marinaro MichaelEVP & President, Surgical OUAug 02 '24Option Exercise0.001,670043,801Aug 06 06:12 PM
Kirk Jennifer MChief Accounting OfficerAug 02 '24Option Exercise0.001,138028,980Aug 06 06:12 PM
Fong Ivan KEVP GENERAL COUNSEL & SECRAug 02 '24Option Exercise0.0014,514063,750Aug 06 06:11 PM
Walter Matthew R.SVP, Chief HR OfficerJul 18 '24Option Exercise62.7649230,87817,580Jul 19 04:40 PM
Martha GeoffreyChairman and CEOJun 07 '24Option Exercise62.7619,1131,199,532162,461Jun 11 06:53 PM
Martha GeoffreyChairman and CEOJun 07 '24Sale83.7719,1131,601,001143,348Jun 11 06:53 PM
Marinaro MichaelEVP & President, Surgical OUApr 08 '24Sale83.1485471,00227,925Apr 09 04:08 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Option Exercise69.0730,6952,120,12178,984Feb 23 05:18 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Sale85.1330,6952,613,05548,289Feb 23 05:18 PM
Wall Brett A.EVP & Pres NeuroscienceDec 19 '23Sale82.174,997410,60328,910Dec 20 11:41 AM